Tiantan bio | Briefing, News, Analysis, Research, Data

Tiantan bio

Tiantan bio diagnostic supplies and other biological products

Tiantan Bio is a vaccine reagent developer, focusing on the research and production of vaccines, blood preparations, diagnostic supplies and other biological products, mainly to provide users with hepatitis B vaccine, polio vaccine, MMR vaccine, influenza vaccine, chickenpox vaccine and other products, its own Changchun Chijian Biological Products Co.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jun 8, 1998

HQ location

Beijing, China

Legal name

Beijing Tiantan Biological Products Corporation Limited

Website

http://www.tiantanbio.com/

ttsw@sinopharm.com

Employees

1001-5000

All
News
Analysis
Research

Briefing Feb 16, 2023 12:51 PM · Healthcare

Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A

Briefing Feb 07, 2023 12:11 PM · Healthcare

ForLong Biotech Nets Over CNY 100 Mn in Series A

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Feb 07, 2023 10:59 AM · Healthcare

CytoCan Corp. Nets CNY 10 Mn in Seed Round

Briefing Jan 30, 2023 10:44 AM · Healthcare

Levostar Completes Pre-A Financing Round to Further Invest in CGT

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Jan 18, 2023 10:59 AM · Healthcare

BlissBio Nets Over CNY 100 Mn in Series B+

Briefing Sep 21, 2022 10:38 AM · Healthcare

Weiyou Gene Nets Tens of Millions of CNY in Series Pre-A Round

Briefing Sep 16, 2022 11:10 PM · Healthcare

NaviSeed Nets Tens of millions of CNY in Angel Round

Briefing Sep 13, 2022 05:30 PM · Healthcare

Nuwacell Nets Hundreds of Mns of CNY in Series A

Healthcare, Technology

Trump Launches "Section 232 Investigations" into Semiconductors and Pharmaceuticals

Apr 16, 2025 02:28 PM

white and black earbuds on white textile

Healthcare

China's First Modified New Drug of Docetaxel Successfully Went to the US

Feb 19, 2025 10:41 AM

Briefing Aug 31, 2022 08:30 PM · Healthcare

Enitiatebio Nets One Hundred Million of CNY in Series A Round

Briefing May 23, 2022 11:10 AM · Healthcare | Industrials | Financials

Monitoring of main funds of star mine: Top 10 list of early trading

Briefing Apr 25, 2022 06:35 PM · Healthcare | Financials | Automotive

Nanomicro Technology: first release of a new product of protein A affinity chromatography medium

Technology, Healthcare · Interview

Under the Fractured Global Supply Chain, How Is United Imaging Shaping a Global "Chain"

Under the Fractured Global Supply Chain, How Is United Imaging Shaping a Global "Chain" Connection?

Jan 08, 2025 06:10 PM

Healthcare · Interview

How Can MedTech Leverage Technological Innovation and Strategic Precision to Go-Global

How Can MedTech Companies Leverage Technological Innovation and Strategic Precision to Expand Globally? | Highlights from GGF2024

Jan 08, 2025 04:28 PM

Briefing Mar 15, 2022 06:19 PM · Healthcare | Financials

It is said that Yin Xiyue will not send special envoys to China, Russia and Japan, but only to the United States and the European Union

Briefing Jan 13, 2022 05:49 PM · Technology | Consumer Staples | Healthcare

Guangdong Securities Regulatory Bureau issued a warning letter to Zhengzhong Zhujiang certified public accountants

Briefing Oct 20, 2021 06:11 PM

Five departments including the central bank: encourage financial institutions to incorporate the application of open source technology into their informatization development plans

Briefing Mar 29, 2021 09:30 PM · Technology | Consumer Staples | Real Estate

Annual report of Shanghai Hong Kong Group: net profit in 2020 decreased by 8.33% year-on-year, and it is planned to pay 1.28 yuan for 10 shares

EqualOcean Analysis